Literature DB >> 3118415

Platelet-activating factor induces leukotriene C4 synthesis by purified human eosinophils.

P L Bruijnzeel1, P T Kok, M L Hamelink, A M Kijne, J Verhagen.   

Abstract

Platelet-activating factor, at a concentration of 10 microM, was capable of inducing leukotriene C4 synthesis by eosinophils of healthy donors, i.e. (3.1 +/- 0.3) x 10(6) molecules leukotriene C4/cell (n = 31, mean +/- SEM, cell purity 87 +/- 2%). Reversed-phase high performance liquid chromatography analysis demonstrated the exclusive synthesis of leukotriene C4. At a concentration of 1 microM, platelet-activating factor was capable of significantly enhancing the calcium ionophore A23187, the opsonized zymosan or the arachidonic acid induced leukotriene C4 synthesis by eosinophils. These results show that PAF is capable of inducing and enhancing the leukotriene C4 formation by human eosinophils.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3118415     DOI: 10.1016/0090-6980(87)90244-9

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  11 in total

Review 1.  The diverse effects of mast cell mediators.

Authors:  Colleen Hines
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

Review 2.  The role of platelet activating factor in allergic respiratory disease.

Authors:  C P Page
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

3.  Priming effect of platelet activating factor on leukotriene C4 from stimulated eosinophils of asthmatic patients.

Authors:  K Shindo; K Koide; Y Hirai; M Sumitomo; M Fukumura
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

4.  Inhibitory effects of nedocromil sodium on the in vitro induced migration and leukotriene formation of human granulocytes.

Authors:  P L Bruijnzeel; R A Warringa; P T Kok; M L Hamelink; J Kreukniet
Journal:  Drugs       Date:  1989       Impact factor: 9.546

5.  Leukotriene C4 formation by purified human eosinophils can be induced by arachidonic acid in the absence of calcium-ionophore A23187.

Authors:  P T Kok; M L Hamelink; G M Kijne; J Verhagen; L Koenderman; G A Veldink; P L Bruynzeel
Journal:  Agents Actions       Date:  1989-01

6.  Platelet activating factor and tracheobronchial respiratory glycoconjugate release in feline and human explants: involvement of the lipoxygenase pathway.

Authors:  J D Lundgren; M Kaliner; C Logun; J H Shelhamer
Journal:  Agents Actions       Date:  1990-06

Review 7.  Platelet-activating factor: receptors and signal transduction.

Authors:  W Chao; M S Olson
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

8.  Asthma Status and Risk of Incident Myocardial Infarction: A Population-Based Case-Control Study.

Authors:  Duk Won Bang; Chung-Il Wi; Eun Na Kim; John Hagan; Veronique Roger; Sheila Manemann; Brian Lahr; Euijung Ryu; Young J Juhn
Journal:  J Allergy Clin Immunol Pract       Date:  2016-05-04

9.  Platelet activating factor amplifies human neutrophil adherence to bovine endothelial cells: evidence for a lipoxygenase dependent mechanism.

Authors:  B Damtew; P J Spagnuolo
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

10.  Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics.

Authors:  C Kroegel; H Matthys
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.